Drug Profile
Recombinant human growth hormone - GenBioPro
Alternative Names: GengrowinLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator GenBioPro
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins; Somatostatins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cachexia; Dwarfism; Turner's syndrome